The story of Sildenafil presents a intricate picture for shareholders. While the initial launch generated substantial returns, the lapse of its patent opened the door to cheaper alternatives, dramatically eroding https://bookmarkeasier.com/story21484831/viagra-and-pharma-a-precarious-opportunity